Division of Infectious Disease Research FY2018 List of Projects - Research Program on HIV/AIDS
| First Year | Final Year | PrincipalInvestigator | Affiliation | Project Title | |
|---|---|---|---|---|---|
| FY2016 | FY2018 | Hiroaki Mitsuya | Kumamoto University Hospital | Distinguished Invited Professor | Research and development of novel anti-HIV agents potent against multi-drug-resistant HIV variants with high CNS penetration |
| FY2016 | FY2018 | Shuzo Matsushita | Kumamoto University | Professor | Development of novel treatment strategy towards cure of HIV-1 infection using neutralizing antibodies |
| FY2016 | FY2018 | Kazutaka Terahara | National Institute of Infectious Diseases | Senior Researcher | Protective efficacy of a CD8+ T cell-inducing HIV vaccine against intestinal mucosal infection |
| FY2016 | FY2018 | Hironori Sato | National Institute of Infectious Diseases | chief | Creation of new research bases of structural and evolutionary biology of HIV Gag proteins for drug seeds discovery |
| FY2016 | FY2018 | Kazuhisa Yoshimura | National Institute of Infectious Diseases | Division Chief | Study for long-term trends in newly diagnosed and transmitted-drug resistant HIV in Japan |
| FY2016 | FY2018 | Shigeyoshi Harada | National Institute of Infectious Diseases | Senior Researcher | Discovery of novel HIV entry inhibitors through structural basis of Env glycoprotein trimers |
| FY2016 | FY2018 | Harutaka Katano | National Institute for Infectious Diseases | Team leader | Research on pathogenesis, prophylaxis and treatment for Kaposi sarcoma and its associated diseases |
| FY2016 | FY2018 | Seiji Okada | Kumamoto University | Professor | Establishment of comprehensive medical system for AIDS related malignant lymphoma in Japan |
| FY2017 | FY2019 | Hirofumi Akari | Kyoto University | Professor | Fundamental and applied research on the development of HIV cure therapeutics |
| FY2017 | FY2019 | Hiroyuki Gatanaga | National Center for Global Health and Medicine | Chief | Study for HIV infection control and complication with new drugs |
| FY2018 | FY2020 | Tetsuro Matano | National Institute of Infectious Diseases | Director | Study for the development of HIV vaccines inducing functional antibodies |
| FY2018 | FY2020 | Shinya Suzu | Kumamoto University | Professor | Study aiming at the identification and eradication of bona fide HIV reservoirs |
| FY2018 | FY2020 | Ai Tachikawa | National Institute of Infectious Diseases | chief | Research on improvement of immunopathogenesis for HIV cure |
| FY2018 | FY2020 | Yoshio Koyanagi | Kyoto University | Professor | Analysis of HIV regulome and generation of HIV cure strategy |
| FY2018 | FY2020 | Kenji Maeda | National Center for Global Health and Medicine | Section Chief | Research on the deelopment of anti-HIV drugs with a novel mechanism of action to cure HIV |
| FY2018 | FY2020 | Katsuji Teruya | National Center for Global Health and Medicine | Chief Physician | Study on appropriate management of opportunistic illnesses in the era of early and prolonged ART |
| FY2018 | FY2020 | Tsukasa Ohomori | Jichi Medical University | Professor | A study to create new generation treatments and diagnosis for cure of hemophilia as an HIV-related disorder |
| FY2018 | FY2020 | Osamu Noyori | Kumamoto University | Postdoctoral researcher | Study of a novel route of intercellular HIV spread |
| FY2018 | FY2020 | Kei Sato | Kyoto University | Lecturer | Investigation of synergistic/contrary anti-HIV-1 responses mediated by innate, intrinsic and acquired immunity |
| FY2018 | FY2020 | Kei Miyakawa | Yokohama City University School of Medicine | Senior Lecturer | Development of spatiotemporal analysis for HIV spread |
| FY2018 | FY2020 | Nozomi Kuse | Kumamoto University | Assistant Professor | Induction of HIV-1-specific CD8+ T cells with super-function from naïve T cells |
| FY2018 | FY2020 | Hiroyuki Yamamoto | National Institute of Infectious Diseases | Chief (Group leader) | Analysis of virus-specific B-cell responses as a platform of prophylactic and therapeutic HIV neutralizing antibody induction |
Last updated 04/25/18